Furthermore, another study showed decreased levels of high molecular weight adiponectin in MGUS patients who progressed to MM (4.5 ± 0.5 μg/mL) compared to MGUS who did not progress to MM (6.4 ± 1.6 μg/mL). This evidence concerns the gene ADIPOQ and Miyoshi myopathy.